Literature DB >> 23921572

SNPs and interaction analyses of IRF6, MSX1 and PAX9 genes in patients with non‑syndromic cleft lip with or without palate.

Tao Song1, Di Wu, Yongqian Wang, Haidong Li, Ningbei Yin, Zhenmin Zhao.   

Abstract

Non‑syndromic cleft lip with or without cleft palate (NSCL/P) is a common congenital deformity, often associated with missing or deformed teeth. The genes interferon regulatory factor 6 (IRF6), muscle segment homeobox 1 (MSX1) and paired box gene 9 (PAX9) are important for the development of the maxillofacial region and dentition. The aim of this study was to explore how genetic variations in IRF6, MSX1 and PAX9, as well as gene‑gene interactions, are associated with NSCL/P. We investigated 9 IRF6 tag single nucleotide polymorphisms (SNPs), 2 MSX1 tag SNPs and 8 PAX9 tag SNPs selected from HapMap data from the Chinese population. The SNPs were examined for associations with NSCL/P in 204 patients and 226 controls. The results demonstrated a significant association between NSCL/P and rs2073485, rs2235371, rs2236909 and rs861020 in the IRF6 gene, and haplotype analysis supported these findings. A marginally significant difference was observed in the NSCL/P group for rs17176643 in the PAX9 gene compared to the control group. The results of gene‑gene interaction analyses also indicated that the combination of rs2073485, rs2235371 or rs2236909 in IRF6 and rs17176643 in PAX9, increased the risk of NSCL/P. Thus, our study provided additional understanding of IRF6 variations in patients with NSCL/P and suggested that interactions between the IRF6 and PAX9 genes are potentially important for susceptibility to NSCL/P.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23921572     DOI: 10.3892/mmr.2013.1617

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

1.  Molecular Diagnostics and In Utero Therapeutics for Orofacial Clefts.

Authors:  J D Oliver; E C Turner; L R Halpern; S Jia; P Schneider; R N D'Souza
Journal:  J Dent Res       Date:  2020-07-01       Impact factor: 6.116

2.  A cleft lip and palate gene, Irf6, is involved in osteoblast differentiation of craniofacial bone.

Authors:  Jake Thompson; Fabian Mendoza; Ethan Tan; Jessica Wildgrube Bertol; Arju S Gaggar; Goo Jun; Claudia Biguetti; Walid D Fakhouri
Journal:  Dev Dyn       Date:  2019-02-07       Impact factor: 3.780

3.  Gene-Gene Interactions among SPRYs for Nonsyndromic Cleft Lip/Palate.

Authors:  R Zhou; M Wang; W Li; S Wang; Z Zhou; J Li; T Wu; H Zhu; T H Beaty
Journal:  J Dent Res       Date:  2018-10-01       Impact factor: 6.116

4.  Association between BMP4 rs17563 polymorphism and NSCL/P risk: a meta-analysis.

Authors:  Yuan-Yuan Hu; Chuan-Qi Qin; Mo-Hong Deng; Yu-Ming Niu; Xing Long
Journal:  Dis Markers       Date:  2015-01-12       Impact factor: 3.434

Review 5.  Association between IRF6 and 8q24 polymorphisms and nonsyndromic cleft lip with or without cleft palate: Systematic review and meta-analysis.

Authors:  Kachin Wattanawong; Sasivimol Rattanasiri; Mark McEvoy; John Attia; Ammarin Thakkinstian
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-08-11

6.  Interaction Effect of RsaI and BamHI Polymorphisms of TGFα, BMP2 and BMP4 on the Occurrence of Non-Syndromic Cleft Lip and Palate in Iranian Patients.

Authors:  Saba Samadi; Asghar Ebadifar; Hamid Reza Khorram Khorshid; Koorosh Kamali; Mohammadreza Badiee
Journal:  Avicenna J Med Biotechnol       Date:  2018 Oct-Dec

7.  Association of Nucleotide Variants of GRHL3, IRF6, NAT2, SDC2, BCL3, and PVRL1 Genes with Nonsyndromic Cleft Lip With/Without Cleft Palate in Multigenerational Families: A Retrospective Study.

Authors:  Praveen Kumar Neela; Srinivas Reddy Gosla; Akhter Husain; Vasavi Mohan; Sravya Thumoju; B V Rajeshwari
Journal:  Contemp Clin Dent       Date:  2021-06-14

8.  DOT: Gene-set analysis by combining decorrelated association statistics.

Authors:  Olga A Vsevolozhskaya; Min Shi; Fengjiao Hu; Dmitri V Zaykin
Journal:  PLoS Comput Biol       Date:  2020-04-14       Impact factor: 4.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.